INTRODUCTION
Anxiety disorders, primarily characterized by pathological anxiety, are very common in the general population with estimates ranging from 20 to 30 percent, and the lifetime prevalence rate is calculated at 16.6 percent.[1] It is to be noted that pathological anxiety is experienced as more intense and exaggerated which arises without any real threat.
The word anxiety was taken from the Latin root “anxieta” meaning disturbance in the mind about an uncertain event, and the Greek root “anxo” meaning to squeeze, strangle, or press tight.[2]
Anxiety is an unpleasant emotional state that is associated with psychophysiological changes as a result of an intrapsychic conflict. Anxiety disorder is a disorder in which the most prominent disturbance is anxiety or in which patients experience anxiety when they refuse to give in to their symptoms.[3]
Panic is an acute, intense attack of anxiety associated with disorganization in personality. It is characterized by overwhelming anxiety and feelings of impending doom. A panic attack is an acute intense anxiety episode, which occurs in panic disorder (PD), major depression, schizophrenia, and somatization disorder. PD is characterized by acute intense anxiety attacks in the presence or absence of agoraphobia.[3]
The onset of panic symptoms is often spontaneous and rapid. Many patients seek help in an emergency department (ED) because of these characteristics, combined with its overwhelming intensity.[4]
Anxiety-related complaints are commonly associated with alcohol and substance abuse, which further complicates the emergency physician’s assessment.[5]
PDs and exacerbations of previous acute stress symptoms are common patient presentations in the ED for primary anxiety disorders. Individuals with anxiety disorders may feel debilitated during an anxiety attack and feel embarrassed after the episode. To support the patient both during and after the anxiety episode, it is essential for ED clinicians to be aware of anxiety and PDs.[6] Table 1 outlines clinical predictors of anxiety caused by an underlying medical disorder.
Table 1.
Predictors of anxiety caused by an underlying medical issue[7]
| Onset of anxiety symptoms after age of 35 years |
| Lack of personal or family history of an anxiety disorder |
| Lack of childhood history of significant anxiety, phobias, or separation anxiety |
| Lack of avoidance behavior |
| Absence of significant life events generating or exacerbating the anxiety symptoms |
| Poor response to antianxiety agents |
CLINICAL PRESENTATION
In ED, anxiety presentations may be classified into four groups[5]:
Primary psychiatric illness, such as generalized anxiety disorder
Response to a stress or stressful event, such as acute stress disorder
Medical conditions or substance abuse that mimic the symptoms of anxiety, such as hyperthyroidism
Anxiety disorder comorbid with another physical or mental illness
Six stages of development have been identified for PD, with stage 1 or stage 2 being the most common for patients. These stages are (1) limited symptom attack, (2) full panic attack, (3) hypochondriasis, (4) limited phobic avoidance, (5) extensive phobic avoidance, and (6) secondary depression. Stage progression is associated with increasing degrees of disability and corresponding treatment implications.[8] It is believed that the disorder is less likely to worsen if the diagnosis is made in stage 1 or 2 and treated.[9] Table 2 outlines various stages of PD.
Table 2.
Stages of panic disorder[10]
| Stage | Name of the stage | Symptomatology |
|---|---|---|
| Stages | ||
| I | Limited symptom attack | Patients display fewer than the four symptoms necessary for diagnosis of panic disorder. |
| II | Panic attack | Patients meet the definition of panic disorders with the appropriate frequency, duration, and four or more of the symptoms. |
| III | Hypochondrias | Patient becomes preoccupied with concerns about medical illness, despite medical assurances. The panic attacks may become associated with environmental stimuli. This is known as phobic avoidance behavior. Driving and going to stores or shopping malls are the most frequent fears. |
| IV | Agoraphobia | |
| V | Extensive phobic avoidance | |
| VI | Secondary depression | It is believed to result from progressive disability and demoralization. |
The main distinguishing feature of PD is the combination of physical and cognitive symptoms. The onset is rapid, reaching its peak within 10 min and the attack around 1 h. The typical patient experiences 2–4 attacks per week, commonly accompanied by anticipatory anxiety.[11]
Panic attack
A brief period of intense fear or discomfort in which ≥4 of the following signs or symptoms occur abruptly and peak within 10 min[12]:
Palpitations, pounding heart, or accelerated heart rate
Sweating
Trembling or shaking
Sensation of shortness of breath or smothering
Feeling of choking
Chest pain or discomfort
Nausea or abdominal distress
Feeling dizzy, unsteady, light-headed, or faint
Derealization (feelings of unreality) or depersonalization (being detached from oneself)
Fear of losing control or going crazy
Fear of dying
Parasthesis (numbness or tingling sensations)
Chills or hot flushes.
Table 3 outlines the typical and atypical symptoms of panic attacks.
Table 3.
Typical and atypical symptoms of panic attacks[4]
| Typical symptoms | Atypical symptoms |
|---|---|
| Tachycardia, palpitations “Atypical” chest pain | Vice-like/crushing chest pain Pleuritic chest pain |
| Trembling, shaking | Shaking rigor |
| Sweating | Diaphoresis (generalized, drenching) |
| Dyspnea | Stridor |
| Subjective weakness in arms and legs | Objective muscular weakness Overt lack of coordination |
| Flushes or chills | Fever, generalized erythema, or rash |
| Dry mouth Choking sensation | Mechanical inability to swallow |
| Dizziness, lightheaded feeling | True vertigo, syncope |
| Depersonalization, derealization | Disorientation to person, time, or place |
| Nausea, abdominal distress | Vomiting (projectile, bilious, or recurrent) |
| Fear of losing control or other “irrelevant” catastrophe | Bizarre behavior (unrelated to fear of the attack) |
PD: Recurrent, sudden panic attacks that are followed by a minimum of 1 month of persistent concern about having another panic attack, worry about the potential implications or consequences of the attacks, or a significant change in behavior related to the attacks.[11]
Table 4 outlines the medical conditions that may cause anxiety.
Table 4.
Medical conditions that may cause anxiety[13]
| System | Conditions |
|---|---|
| Cardiovascular diseases | Congestive heart failure, acute chest pain, acute myocardial infarction, angina, anemia, hypotension, hypertension, arrhythmias, hypovolemia |
| Respiratory | Asthma, acute and chronic bronchitis, COPD, pneumonia, hyperventilation, sleep apnea |
| Metabolic syndrome | Hypocalcemia, hypokalemia, porphyria, pellagra, uremia |
| Endocrine disorders | Hyperadrenocorticism, pituitary dysfunction, hyperthyroidism, hypothyroidism, parathyroid dysfunction, pheochromocytoma, hypoglycemia, virilization disorders in females, premenstrual syndrome |
| Neurologic disorders | Cerebrovascular disease, cerebral neoplasm, encephalitis, migraines, subarachnoid hemorrhage, closed head injuries, multiple sclerosis, Wilson disease, vestibular dysfunctions, dementia, delirium, Huntington’s disease, temporal lobe diseases, seizure disorders, psychomotor epilepsy |
| Inflammatory disorders | Systemic lupus erythematosus, rheumatoid arthritis, temporal arteritis, fibromyalgia, allergic reactions |
| Toxicity | Caffeine intoxication, amphetamines, heavy metals, vasopressors and sympathomimetic agents, organophosphates, alcohol, opiates, phencyclidines, cocaine, ecstasy |
| Infectious and other diseases | Septicemia, carcinoid syndrome, infectious mononucleosis, AIDS, systemic malignancies, subacute bacterial endocarditis, gastrointestinal hemorrhage |
| Miscellaneous | Irritable bowel syndrome, dyspepsia, GERD, shingles (herpes zoster) |
AIDS, acquired immunodeficiency syndrome; COPD, chronic obstructive pulmonary disease; GERD, gastroesophageal reflux disease; HIV, human immunodeficiency virus
Management of the PD
Assessment
Patients with PD or anxiety usually present to the ED with somatic symptoms of breathlessness, palpitations, chest pain, etc. It is not uncommon for them to be diagnosed as having an acute respiratory or cardiac event or any other physical illness. Even though the patient is having a panic attack, it is highly essential to rule out all acute physical emergencies. A proper history taking along with a careful physical examination of the vital parameters and certain basic investigations help the emergency physician to rule out a physical illness.
These include the measurement of vital data like blood pressure, oxygen saturation, pulse rate and characteristics, and respiratory rate. Hematological investigations like complete blood counts, serum electrolytes, blood glucose levels, arterial blood gas analysis, thyroid function tests, and renal function tests are to be done. Electrolyte abnormalities like reduced ionized calcium and serum phosphate levels are usually seen in patients with hyperventilation. An electrocardiogram to rule out any acute cardiac abnormalities can be done.
Point of care ultrasonography of the lungs, bedside X-ray of the chest, and peak flowmetry to rule out any respiratory abnormalities are advisable. A toxicological screening to rule out any drug abuse is also helpful in an emergency setting. After ruling out the possible physical causes, the patient could be diagnosed with a PD or an anxiety disorder.
Application of DSM-V or ICD-10 guidelines in an emergency setting could be difficult due to the unavailability of a psychiatrist in the ED. This could lead to underdiagnosing or misdiagnosing the PD. Hence, using certain screening tools that can be applied by an emergency physician or any general physician could be useful in diagnosing a patient with panic or anxiety disorders.
Screening tools
Following are some of the available screening tools that can be used by physicians or primary care doctors in an emergency setting [Table 5]:
Table 5.
Screening tools for anxiety/panic disorder
| Anxiety Disorder | Panic Disorder |
|---|---|
| Anxiety Disorder Diagnostic Questionnaire[14] | Panic Disorder Self-Report[18] |
| Generalized Anxiety Disorder 7[15] | Panic Disorder Severity Scale[19] |
| Beck Anxiety Inventory[16] | Panic and Agoraphobia Scale[20] |
| Hamilton Anxiety Rating Scale[17] | NIMH Panic Questionnaire[21] |
| Panic associated symptoms scale[22] |
Treatment in an emergency setting
After careful history taking and a careful assessment, patients can be diagnosed with a physical illness or with anxiety or PD. If the patient is found to have a physical illness, he or she can be treated by the emergency physician immediately and later referred to the concerned specialist physician. If the patient is found to have a psychogenic panic attack or an anxiety disorder, he can be treated by the emergency physician to subvert the crisis situation and then referred to a psychiatrist. However, it is not uncommon for patients diagnosed with primary mental illness to have an underlying medical condition, and should be taken into consideration while treating the patient. Patients can be treated using both pharmacological and non-pharmacological measures.
Pharmacotherapy
The most important step in the management is to abort the panic attack. A benzodiazepine with rapid onset of action is the choice of pharmacotherapy. Alprazolam, lorazepam, and clonazepam are used to treat anxiety/panic symptoms. Alprazolam is usually started at a low dose of 0.25 mg, three times a day, but doses of 4 mg/day or more may be required.[23] The initial starting dose of lorazepam is 2 mg to 3 mg, can repeat the dose 2 to 3 times per day; the maximum dosage is 10 mg per day.[24] It can also be administered via intravenous (IV) or intramuscular (IM) injection (2 mg/mL solution, and 4 mg/mL solution). The onset of its action is 1 to 3 min if administered IV and 15 to 30 min if administered IM. Clonazepam is given orally at a starting dose of 0.25 mg and can be used with a maximum dose of 4 mg/day. Abrupt cessation of the benzodiazepines might lead to withdrawal and hence careful tapering of the medication must be done. Caution must be taken with the use of long-term benzodiazepines because of the dependence potential.
In the long-term treatment of anxiety/PD, selective serotonin reuptake inhibitors (SSRIs) are the first-line medications. Examples of SSRIs approved by the FDA to treat the PD include escitalopram, paroxetine, sertraline, and fluoxetine. Even though all of them are equally effective, because of their sedating property, paroxetine is more commonly used.[25] These medications must be titrated slowly and take several weeks to be effective. Common side effects of SSRIs include nausea, diarrhea, constipation, headache, tremors, agitation, dizziness, sweating, and sexual dysfunction. Tricyclic antidepressants include imipramine, clomipramine, etc. Serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine are also used in the treatment of PD. A brief course of alprazolam can be prescribed in conjunction with an SSRI for short-term management of PD and should be slowly titrated when the therapeutic actions of the SSRI become apparent (2–4 weeks). Medications and their dosages used in PD are summarized in Table 6.
Table 6.
Medications used in anxiety/panic disorder
| Drug | Initial dose | Maintenance dose |
|---|---|---|
| Benzodiazepines | ||
| Alprazolam | 0.25-0.5 mg tid | 0.5-2 mg tid |
| Lorazepam | 1-2 mg bid | 1-2 mg tid |
| Clonazepam | 0.25-0.5 mg bid | 0.5-2 mg bid |
| SSRI | ||
| Paroxetine | 5-10 mg | 20-60 mg |
| Fluoxetine | 20 mg | 20-60 mg |
| Escitalopram | 10 mg | 10-20 mg |
| Sertraline | 12.5-25 mg | 50-200 mg |
| TCA | ||
| Clomipramine | 5-12.5 mg | 50-125 mg |
| Imipramine | 10-25 mg | 150-500 mg |
| Desipramine | 10-25 mg | 150-200 mg |
| SNRI | ||
| Venlafaxine | 6.25-25 mg | 50-150 mg |
Non-pharmacological therapy
Most panic attacks spontaneously resolve within half an hour, and patients can sometimes present with the attacks subsiding or with feelings of anticipatory anxiety. Therefore, during such an attack, the treating physician should reassure the patient and explain the brief nature of the illness. Psychoeducation of the patient and the caregivers regarding the course and prognosis of the illness helps in alleviating the anxiety. For further information on psychoeducation in the management of anxiety, refer to Clinical Practice Guidelines for Psychoeducation in Psychiatric Disorders General Principles of Psychoeducation.[26] In the long term, psychotherapies such as cognitive behavioral therapy,[27] interpersonal therapy, and mindfulness therapy can be used to treat PD, but also take effect after several weeks. Therefore, healthcare providers in the ED should properly refer and educate on general lifestyle recommendations to reduce and identify any anxiety-related symptoms, such as eliminating stimulants, obtaining adequate sleep, and exercising daily. In addition, relaxation techniques[17] can easily be administered in ED settings and have the potential to reduce anxiety. Deep breathing exercises,[28] which involve consciously slowing respirations and focusing on taking regular slow deep breaths have been shown to reduce anxiety or panic symptoms. Another strategy may include guided imagery,[29] where the emergency physician encourages the patient to imagine a serene location free of stress. Both of these methods may have a profound effect on the anxiety of patients who present with a panic attack or known PD.
Role of emergency physicians
PD is a very common presentation in the primary care setting, especially in an ED. Most of the patients have cardiac, gastrointestinal, ear, nose, and throat (ENT), or neurological comorbidities. As the first point of contact with the patients, emergency physicians have an important role in the management of PDs. A holistic history and clinical assessment are of paramount importance. Early recognition and management help to reduce both morbidity and mortality. The emergency physician should be able to abate the panic attack and put in a referral to a psychiatrist especially if the patient has suicidality or any self-neglect or inadequate response to the primary intervention. Early referral decreases overall cost in the assessment and management of PDs.[30] The management of patients presenting to the emergency department has been summarized in Figure 1.
Figure 1.

Algorithm depicting the management of patients presenting to the emergency department with anxiety/panic symptoms
SUMMARY
Anxiety/PD is common in the general population and often presents to the ED. The emergency physician must be able to identify the underlying cause for the presentation, which could be either a primary mental illness or an underlying medical condition presenting with the symptoms of anxiety/PD to initiate proper treatment. Basic investigations help in the assessment of the symptoms. If the cause is an underlying medical illness, referral to the concerned specialist would be helpful and if symptoms are purely due to a primary mental illness, the patient can be screened for an anxiety or PD. Early and timely recognition of primary anxiety disorder helps in avoiding unnecessary investigations and can be treated with both pharmacological and non-pharmacological options. The main aim is to calm down the patient and abort the panic attack. Benzodiazepines and SSRIs remain the mainstay of treatment. Reassurance and psychoeducation of the patient as well as his caregivers help a long way in the management of the symptoms. Judicious use of medication, patient education, and referral to a physician whenever necessary improve the outcome of patients with this otherwise potentially disabling disorder.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- 1.Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17:327–35. doi: 10.31887/DCNS.2015.17.3/bbandelow. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sandeep K, Rajmeet S. Role of different neurotransmitters in anxiety:A systemic review. Int J Pharm Sci Res. 2017;8:411–21. [Google Scholar]
- 3.Sadock BJ, Sadock VA. Kaplan and Sadock's Concise Textbook of Clinical Psychiatry. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008. [Google Scholar]
- 4.Pollard CA, Lewis LM. Managing panic attacks in emergency patients. J Emerg Med. 1989;7:547–52. doi: 10.1016/0736-4679(89)90164-9. [DOI] [PubMed] [Google Scholar]
- 5.Felder ML, Perry MA. The patient with anxiety disorders in the emergency department. In: Zun LS, Chepenik LG, Mallory MNS, editors. Behavioral Emergencies for the Emergency Physician. Cambridge: Cambridge University Press; 2013. pp. 76–82. [Google Scholar]
- 6.Lentz C. Anxiety and mood disorders in an emergency context. Big Book of Emergency Department Psychiatry. New York: Productivity Press; 2017. pp. 147–76. [Google Scholar]
- 7.Zun LS, Nathan JB. Rosen's Emergency Medicine:Concepts and Clinical Practice. 7th ed. Philadelphia, PA: Mosby Elsevier; 2009. Anxiety disorders. [Google Scholar]
- 8.Merritt TC. Recognition and acute management of patients with panic attacks in the emergency department. Emerg Med Clin North Am. 2000;18:289–300. doi: 10.1016/s0733-8627(05)70125-5. [DOI] [PubMed] [Google Scholar]
- 9.Noyes R, Clancy J, Hoenk PR, Slymen DJ. The prognosis of anxiety neurosis. Arch Gen Psychiatry. 1980;37:173–8. doi: 10.1001/archpsyc.1980.01780150063006. [DOI] [PubMed] [Google Scholar]
- 10.Zun LS. Panic disorder:Diagnosis and treatment in emergency medicine. Ann Emerg Med. 1997;30:92–6. doi: 10.1016/s0196-0644(97)70117-3. [DOI] [PubMed] [Google Scholar]
- 11.Manjunatha N, Ram D. Panic disorder in general medical practice-A narrative review. J Family Med Prim Care. 2022;11:861–9. doi: 10.4103/jfmpc.jfmpc_888_21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-5. Arlington, VA: American Psychiatric Publishing; 2013. [Google Scholar]
- 13.Tan DT, Khouzam H, Gill T. Handbook of Emergency Psychiatry. 1st ed. Philadelphia: Mosby; 2007. The Acutely Anxious Patient; pp. 214–33. [Google Scholar]
- 14.Norton PJ, Robinson CM. Development and evaluation of the anxiety disorder diagnostic questionnaire. Cogn Behav Ther. 2010;39:137–49. doi: 10.1080/16506070903140430. [DOI] [PubMed] [Google Scholar]
- 15.Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder:The GAD-7. Arch Intern Med. 2006;166:1092–7. doi: 10.1001/archinte.166.10.1092. [DOI] [PubMed] [Google Scholar]
- 16.Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety:psychometric properties. J Consulting Clin Psychol. 1988;56:893. doi: 10.1037//0022-006x.56.6.893. [DOI] [PubMed] [Google Scholar]
- 17.Öst LG, Westling BE. Applied relaxation vs cognitive behavior therapy in the treatment of panic disorder. Behav Res Ther. 1995;33:145–58. doi: 10.1016/0005-7967(94)e0026-f. [DOI] [PubMed] [Google Scholar]
- 18.Newman MG, Holmes M, Zuellig AR, Kachin KE, Behar E. The reliability and validity of the panic disorder self-report:A new diagnostic screening measure of panic disorder. Psychol Assess. 2006;18:49–61. doi: 10.1037/1040-3590.18.1.49. [DOI] [PubMed] [Google Scholar]
- 19.Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Vander Bilt J, et al. Reliability and validity of the Panic Disorder Severity Scale:Replication and extension. J Psychiatr Res. 2001;35:293–6. doi: 10.1016/s0022-3956(01)00028-0. [DOI] [PubMed] [Google Scholar]
- 20.Bandelow B. Panic and Agoraphobia Scale (PAS) Newbury port, Massachussets: Hogrefe &Huber Publishers; 1999. [Google Scholar]
- 21.Scupi BS, Maser JD, Uhde TW. The National Institute of Mental Health Panic Questionnaire:An instrument for assessing clinical characteristics of panic disorder. J Nerv Ment Dis. 1992;180:566–72. doi: 10.1097/00005053-199209000-00004. [DOI] [PubMed] [Google Scholar]
- 22.Argyle N, Deltito J, Allerup P, Maier W, Albus M, Nutzinger D, et al. The Panic-Associated Symptom Scale:Measuring the severity of panic disorder. Acta Psychiatr Scand. 1991;83:20–6. doi: 10.1111/j.1600-0447.1991.tb05506.x. [DOI] [PubMed] [Google Scholar]
- 23.Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015;91:617–24. [PubMed] [Google Scholar]
- 24.Vlastra W, Delewi R, Rohling WJ, Wagenaar TC, Hirsch A, Meesterman MG, et al. Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention. Open Heart. 2018;5:e000833. doi: 10.1136/openhrt-2018-000833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Du Y, Du B, Diao Y, Yin Z, Li J, Shu Y, et al. Comparative efficacy and acceptability of antidepressants and benzodiazepines for the treatment of panic disorder:A systematic review and network meta-analysis. Asian J Psychiatr. 2021;60:102664. doi: 10.1016/j.ajp.2021.102664. [DOI] [PubMed] [Google Scholar]
- 26.Sarkhel S, Singh OP, Arora M. Clinical practice guidelines for psychoeducation in psychiatric disorders general principles of psychoeducation. Indian J Psychiatry. 2020;62(Suppl 2):S319–23. doi: 10.4103/psychiatry.IndianJPsychiatry_780_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Otto MW, Deveney C. Cognitive-behavioral therapy and the treatment of panic disorder:Efficacy and strategies. J Clin Psychiatry. 2005;66(Suppl 4):28–32. [PubMed] [Google Scholar]
- 28.Taylor S. Breathing retraining in the treatment of panic disorder:Efficacy, caveats and indications. Scan J Beha Ther. 2001;30:49–56. [Google Scholar]
- 29.Öst LG, Westling BE, Hellström K. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia. Behav Res Ther. 1993;31:383–94. doi: 10.1016/0005-7967(93)90095-c. [DOI] [PubMed] [Google Scholar]
- 30.Chen YH, Chen SF, Lin HC, Lee HC. Healthcare utilization patterns before and after contact with psychiatrist care for panic disorder. J Affect Disord. 2009;119:172–6. doi: 10.1016/j.jad.2009.02.011. [DOI] [PubMed] [Google Scholar]
